Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin

NCT05467033 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

424

Enrollment

OTHER

Sponsor class

Conditions

Kidney Biopsy

Interventions

DRUG: Desmopressin
DRUG: intravenous infusion NaCl

Sponsor

Medical University of Bialystok